专家文章 | 余加林

搜索
登录

热心肠智库专家文章 | 余加林

2023

CAIdentification of genetic susceptibility in preterm newborns with bronchopulmonary dysplasia by whole-exome sequencing: BIVM gene may play a role

EUR J PEDIATR, 10.1007/s00431-022-04779-z

2021

CAA Study on Fucosyltransferase 2 Gene Polymorphism and Secretion Status Related to Neonatal Necrotizing Enterocolitis

J HEALTHC ENG, 10.1155/2021/7219850

CAThe decrease of fucosylation in intestinal epithelium is related to the development of necrotizing enterocolitis

MOL IMMUNOL, 10.1016/j.molimm.2020.12.036

2020

CAIdentification of progranulin as a novel diagnostic biomarker for early-onset sepsis in neonates

Eur. J. Clin. Microbiol. Infect. Dis, 10.1007/s10096-020-03981-x

CAThe association between enteric viruses and necrotizing enterocolitis

EUR J PEDIATR, 10.1007/s00431-020-03746-w

CAThe microbiota protects against Pseudomonas aeruginosa pneumonia via γδ T cell-neutrophil axis in mice

Microbes Infect, 10.1016/j.micinf.2020.04.003

CAEvolution of the Gut Microbiome in Early Childhood: A Cross-Sectional Study of Chinese Children

FMICB, 10.3389/fmicb.2020.00439

FACA[Accurate use of antibiotics for preterm infants with early-onset sepsis should be taken seriously]

Chinese Journal of Contemporary Pediatrics, 10.7499/j.issn.1008-8830.2020.01.002

2019

CAThe constitution and functional prediction of the microbiota in necrotizing enterocolitis with a gestational age of over 28 weeks

Medicine, 10.1097/MD.0000000000017206

2018

CAPolymorphonuclear Leukocytes or Hydrogen Peroxide Enhance Biofilm Development of Mucoid

MEDIAT INFLAMM, 10.1155/2018/8151362

CAVitamin A and Retinoic Acid Exhibit Protective Effects on Necrotizing Enterocolitis by Regulating Intestinal Flora and Enhancing the Intestinal Epithelial Barrier

Arch Med Res, 10.1016/j.arcmed.2018.04.003

2017

CAUltrasound Microbubbles Enhance the Activity of Vancomycin Against Staphylococcus epidermidis Biofilms In Vivo

J ULTRAS MED, 10.1002/jum.14475

CAAutoinducer-2 Facilitates Pseudomonas aeruginosa PAO1 Pathogenicity in Vitro and in Vivo

FMICB, 10.3389/fmicb.2017.01944

CAAutoinducer-2 Facilitates Pseudomonas aeruginosa PAO1 Pathogenicity in Vitro and in Vivo

FMICB, 10.3389/fmicb.2017.01944

CAAutoinducer-2 Facilitates Pseudomonas aeruginosa PAO1 Pathogenicity in Vitro and in Vivo

FMICB, 10.3389/fmicb.2017.01944

CAAutoinducer-2 Facilitates Pseudomonas aeruginosa PAO1 Pathogenicity in Vitro and in Vivo

FMICB, 10.3389/fmicb.2017.01944

CAAutoinducer-2 Facilitates Pseudomonas aeruginosa PAO1 Pathogenicity in Vitro and in Vivo

FMICB, 10.3389/fmicb.2017.01944

CAAutoinducer-2 Facilitates Pseudomonas aeruginosa PAO1 Pathogenicity in Vitro and in Vivo

FMICB, 10.3389/fmicb.2017.01944

CAAutoinducer-2 Facilitates Pseudomonas aeruginosa PAO1 Pathogenicity in Vitro and in Vivo

FMICB, 10.3389/fmicb.2017.01944

CAAutoinducer-2 Facilitates Pseudomonas aeruginosa PAO1 Pathogenicity in Vitro and in Vivo

FMICB, 10.3389/fmicb.2017.01944